Literature DB >> 3350586

Cytostatic and tumoricidal activities of tumor necrosis factor-treated neutrophils.

H Shau1.   

Abstract

When incubated with recombinant human tumor necrosis factor (TNF), polymorphonuclear neutrophils (PMN) were highly cytostatic to all three tumor cell lines tested. The cytostasis was dose-dependent for both PMN and TNF, and could be neutralized by antibodies specific for TNF. It could also be abrogated by catalase but not by superoxide dismutase (SOD), suggesting that the hydrogen peroxide generated by the TNF-activated PMN was involved in the cytostasis. TNF-treated PMN were also cytotoxic to the tumor cells. However, high level of tumor cytolysis was not evident until after long (greater than 24 h) incubation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3350586     DOI: 10.1016/0165-2478(88)90100-9

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  7 in total

1.  Effects of tumor-necrosis-factor-activated neutrophils on tumor cell survival.

Authors:  H Shau
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  Recombinant human tumour necrosis factor-alpha suppresses synthesis, activity and secretion of lipoprotein lipase in cultures of a human osteosarcoma cell line.

Authors:  K Sakayama; H Masuno; H Okumura; T Shibata; H Okuda
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

3.  Decreased luminol-dependent chemiluminescence response of neutrophils to recombinant human tumour necrosis factor in patients with gastric cancer.

Authors:  I A Schepetkin; N V Cherdyntseva; E V Borunov; I L Skutina; S A Naumov
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

4.  The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment.

Authors:  Ronit Vogt Sionov; Zvi G Fridlender; Zvi Granot
Journal:  Cancer Microenviron       Date:  2014-06-04

5.  Effects of intraperitoneal recombinant interleukin-1 beta in intraperitoneal human ovarian cancer xenograft models: comparison with the effects of tumour necrosis factor.

Authors:  S T Malik; N East; D Boraschi; F R Balkwill
Journal:  Br J Cancer       Date:  1992-05       Impact factor: 7.640

6.  Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line.

Authors:  J S Economou; K Rhoades; R Essner; W H McBride; J C Gasson; D L Morton
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

7.  Enhanced antitumor effect of recombinant human tumor necrosis factor in combination with recombinant human granulocyte colony-stimulating factor in BALB/c mice.

Authors:  M Maeda; N Watanabe; N Tsuji; Y Tsuji; T Okamoto; H Sasaki; S Akiyama; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  1993-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.